Fengqin Li1, Kuikui Zhang2, Ting Xu1, Wenjuan Du1, Bo Yu1, Youbin Liu3, Honggang Nie4. 1. Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. 2. Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. 3. Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. liuyoubin@ems.hrbmu.edu.cn. 4. Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. drnie@163.com.
Abstract
PURPOSE: Present study aims to explore the pathophysiological role of microRNA (miR)-29a in the process of obesity-related cardiomyopathy in human subjects and mice. METHODS: The expression level of circulating exosomal miR-29a was measured in 37 lean and 30 obese human subjects, and correlated with cardiac parameters. The effects of miR-29a on mitochondrial activity and cardiac function were investigated by treatment of miR-29a sponge in primary mouse cardiomyocytes and diet-induced obesity-related cardiomyopathy in mice. RESULTS: The increased circulating miR-29a level was closely associated with impaired human cardiac function, including ejection fraction (r = -0.2663, p < 0.05) and NT-proBNP levels (r = 0.4270, p < 0.001). Exosomes from obese human plasma mediated cardiomyocyte mitochondrial inactivity, but pre-treatment with miR-29a sponge attenuated the exosomal miR-29a-induced reduction of ATP production (p < 0.001), basal oxygen consumption (p < 0.01) and mitochondrial complex I activity (p < 0.01). In vivo mouse study, high fat diet damaged cardiac function, normal structure, and mitochondrial activity, whereas miR-29a sponge improved the cardiac status. CONCLUSIONS: Present study uncovered the correlation between circulating miR-29a and cardiac parameters in human subjects, and provided solid evidence of the therapeutic application of miR-29a sponge in combating obesity-mediated cardiac dysfunction.
PURPOSE: Present study aims to explore the pathophysiological role of microRNA (miR)-29a in the process of obesity-related cardiomyopathy in human subjects and mice. METHODS: The expression level of circulating exosomal miR-29a was measured in 37 lean and 30 obesehuman subjects, and correlated with cardiac parameters. The effects of miR-29a on mitochondrial activity and cardiac function were investigated by treatment of miR-29a sponge in primary mouse cardiomyocytes and diet-induced obesity-related cardiomyopathy in mice. RESULTS: The increased circulating miR-29a level was closely associated with impaired human cardiac function, including ejection fraction (r = -0.2663, p < 0.05) and NT-proBNP levels (r = 0.4270, p < 0.001). Exosomes from obesehuman plasma mediated cardiomyocyte mitochondrial inactivity, but pre-treatment with miR-29a sponge attenuated the exosomal miR-29a-induced reduction of ATP production (p < 0.001), basal oxygen consumption (p < 0.01) and mitochondrial complex I activity (p < 0.01). In vivo mouse study, high fat diet damaged cardiac function, normal structure, and mitochondrial activity, whereas miR-29a sponge improved the cardiac status. CONCLUSIONS: Present study uncovered the correlation between circulating miR-29a and cardiac parameters in human subjects, and provided solid evidence of the therapeutic application of miR-29a sponge in combating obesity-mediated cardiac dysfunction.
Authors: Matthew Kelly; Richard D Bagnall; Roger E Peverill; Lesley Donelan; Louise Corben; Martin B Delatycki; Christopher Semsarian Journal: J Mol Cell Cardiol Date: 2011-07-12 Impact factor: 5.000
Authors: Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh Journal: Nat Med Date: 2004-11-21 Impact factor: 53.440
Authors: Maria Carolina Borges; Debbie A Lawlor; Cesar de Oliveira; Jon White; Bernardo Lessa Horta; Aluísio J D Barros Journal: Circ Res Date: 2016-06-01 Impact factor: 17.367